tailieuchung - Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Đang chuẩn bị liên kết để tải về tài liệu:
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Xuân Thuyết 27 11 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Effective systemic treatments have revolutionized the management of patients with metastatic melanoma, including those with brain metastases. The extent to which these treatments influence disease trajectories close to death is unknown. |

Đang chuẩn bị liên kết để tải về tài liệu:
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Effective systemic treatments have revolutionized the management of patients with metastatic melanoma, including those with brain metastases. The extent to which these treatments influence disease trajectories close to death is unknown. |

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: A prospective study with focus on primary tumor sidedness

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination

Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China

Đang chuẩn bị liên kết để tải về tài liệu: Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Effective systemic treatments have revolutionized the management of patients with metastatic melanoma, including those with brain metastases. The extent to which these treatments influence disease trajectories close to death is unknown. |

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: A prospective study with focus on primary tumor sidedness

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination

Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China

Đang chuẩn bị liên kết để tải về tài liệu:
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases